Sign up to access all valuation multiples
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through four business divisions; Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, along pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of the revenue from the United Kingdom and also operates in the Netherlands and Ireland.
2007
8.8K+
LTM Revenue $914M
LTM EBITDA $181M
$1.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
CVS Group has a last 12-month revenue (LTM) of $914M and a last 12-month EBITDA of $181M.
In the most recent fiscal year, CVS Group achieved revenue of $869M and an EBITDA of $145M.
CVS Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See CVS Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $914M | XXX | $869M | XXX | XXX | XXX |
| Gross Profit | $388M | XXX | $373M | XXX | XXX | XXX |
| Gross Margin | 42% | XXX | 43% | XXX | XXX | XXX |
| EBITDA | $181M | XXX | $145M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 17% | XXX | XXX | XXX |
| EBIT | $117M | XXX | $68.2M | XXX | XXX | XXX |
| EBIT Margin | 13% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $80.1M | XXX | $8.3M | XXX | XXX | XXX |
| Net Margin | 9% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $221M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of September 5, 2025, CVS Group's stock price is GBP 12 (or $16).
CVS Group has current market cap of GBP 865M (or $1.2B), and EV of GBP 1.1B (or $1.5B).
See CVS Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.5B | $1.2B | XXX | XXX | XXX | XXX | $1.12 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of September 5, 2025, CVS Group has market cap of $1.2B and EV of $1.5B.
CVS Group's trades at 1.7x EV/Revenue multiple, and 9.5x EV/EBITDA.
Equity research analysts estimate CVS Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
CVS Group has a P/E ratio of 14.5x.
See valuation multiples for CVS Group and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
| EV (current) | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 8.5x | XXX | 9.5x | XXX | XXX | XXX |
| EV/EBIT | 13.2x | XXX | 16.8x | XXX | XXX | XXX |
| EV/Gross Profit | 4.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | 14.5x | XXX | 26.6x | XXX | XXX | XXX |
| EV/FCF | 19.6x | XXX | 28.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCVS Group's last 12 month revenue growth is 6%
CVS Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $35K for the same period.
CVS Group's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
CVS Group's rule of X is 35% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for CVS Group and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | 12% | XXX | XXX | XXX |
| Rule of 40 | 24% | XXX | 25% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 35% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $35K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 35% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Mad Paws | XXX | XXX | XXX | XXX | XXX | XXX |
| i-Tail | XXX | XXX | XXX | XXX | XXX | XXX |
| Central Garden & Pet | XXX | XXX | XXX | XXX | XXX | XXX |
| Dogness | XXX | XXX | XXX | XXX | XXX | XXX |
| Freshpet | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CVS Group acquired XXX companies to date.
Last acquisition by CVS Group was XXXXXXXX, XXXXX XXXXX XXXXXX . CVS Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was CVS Group founded? | CVS Group was founded in 2007. |
| Where is CVS Group headquartered? | CVS Group is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does CVS Group have? | As of today, CVS Group has 8.8K+ employees. |
| Who is the CEO of CVS Group? | CVS Group's CEO is Mr. Richard William Mark Fairman. |
| Is CVS Group publicy listed? | Yes, CVS Group is a public company listed on LON. |
| What is the stock symbol of CVS Group? | CVS Group trades under CVSG ticker. |
| When did CVS Group go public? | CVS Group went public in 2007. |
| Who are competitors of CVS Group? | Similar companies to CVS Group include e.g. Mad Paws, i-Tail, Central Garden & Pet, Dogness. |
| What is the current market cap of CVS Group? | CVS Group's current market cap is $1.2B |
| What is the current revenue of CVS Group? | CVS Group's last 12 months revenue is $914M. |
| What is the current revenue growth of CVS Group? | CVS Group revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of CVS Group? | Current revenue multiple of CVS Group is 1.7x. |
| Is CVS Group profitable? | Yes, CVS Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of CVS Group? | CVS Group's last 12 months EBITDA is $181M. |
| What is CVS Group's EBITDA margin? | CVS Group's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of CVS Group? | Current EBITDA multiple of CVS Group is 8.5x. |
| What is the current FCF of CVS Group? | CVS Group's last 12 months FCF is $78.6M. |
| What is CVS Group's FCF margin? | CVS Group's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of CVS Group? | Current FCF multiple of CVS Group is 19.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
